12 market signals we’re watching in 2023 (part 1)
We believe that prioritization is essential to understanding the state of healthcare. There’s a lot of noise in this industry—demographic shifts, emerging competitive threats, policy changes, clinical and technological innovations, and more.
We believe that prioritization is essential to understanding the state of healthcare. There’s a lot of noise in this industry—demographic shifts, emerging competitive threats, policy changes, clinical and technological innovations, and more. That makes it difficult to discern what’s truly meaningful and to separate the “signal” from the “noise.” And that’s why we begin our research each year by first identifying meaningful (if granular) signals—data points, dates, and developments. From that curated set of signals, we’re able to distill a yet-smaller set of core “messages” about the present and future state of the industry. And from those messages, we converge on a feasible number of action steps for senior executives to prioritize in any given year.

Our team spent the month of January largely focused on the first step of that annual (and ongoing) research process: identifying the market signals we think are critical for 2023. Our next two posts will cover the 12 that we landed on, beginning with the six that we’re watching in the policy and investment spaces.
Union Healthcare Insight
Log in to continue reading
Not a member yet? Create a free account for limited access.
Related insights
The Great Utilization Shift
For-profit health systems’ financial performance in 2025—and what to expect in 2026
The national insurers’ financial performance in Q4 2025: How the Big Five insurers weathered 2025—and what to expect in 2026